Review Process

Peer (Editorial) Review process

The review process for submissions to Antibody Reports follows a meticulous editorial evaluation. Upon receiving a manuscript, an academic editor with expertise in the field conducts a thorough initial quality check to assess its alignment with the journal's scope, the quality of content, and adherence to editorial policies and ethical standards. Submissions may be returned to authors for changes or clarifications at this stage.

Once a submission is accepted, the editor proceeds to the reviewing phase with the aim of ensuring clarity of the data, scientific rigor, and compliance with our publication guidelines. The Editor-in-Chief, leveraging their expertise and insights from the editorial team, makes the final decision on whether to accept, revise, or reject the submission.

In our review model, the editor assumes the dual role of both reviewer and direct interactor with authors and the Editor-in-Chief. This approach establishes an open review identity and encourages interactive reviewing. It fosters direct reciprocal discussions between reviewers and/or between authors and reviewers, enhancing the collaborative nature of the review process.

Typically, the entire reviewing process takes an average of 20 days.

Editors with conflicts of interest related to a submitted manuscript are recused from both the reviewing process and decision-making. In cases where the conflict involves the Editor-in-Chief, he will also be excluded from the reviewing process. In such instances, another editor will temporarily assume the role of Editor-in-Chief to ensure impartiality and maintain the integrity of the review process.